420570 — J2KBio Co Income Statement

0.000.00%

Last trade - 00:00

HealthcareHighly SpeculativeMicro CapNeutral

Annual income statement for J2KBio Co, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.

	2021 December 31st	R2022 December 31st	2023 December 31st	2024 December 31st	2025 December 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	PROSPECTUS	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts
Standards:	IFRS	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Revenue
Total Revenue	14,219	16,032	28,472	33,129	32,966
Cost of Revenue
Gross Profit	5,929	7,058	11,502	12,657	12,979
Selling / General / Administrative Expenses
Research And Development
Depreciation and Amortization
Unusual Expense / Income
Total Operating Expenses	12,444	13,708	22,872	29,503	30,064
Operating Profit	1,774	2,324	5,600	3,626	2,902
Gain / Loss on Sale of Assets
Total Net Non Operating Interest Income / Expense
Other Net Non Operating Costs
Net Income Before Taxes	1,594	2,183	5,572	-1,361	3,042
Provision for Income Taxes
Net Income After Taxes	1,623	2,064	4,798	-1,671	2,673
Minority Interest
Net Income Before Extraordinary Items
Net Income	1,623	2,086	4,844	-1,653	2,673
Income Available to Common Shareholders Excluding Extraordinary Items
Income Available to Common Shareholders Including Extraordinary Items
Diluted Net Income	1,623	2,086	4,844	-1,653	2,673
Diluted Weighted Average Shares
Basic EPS Including Extraordinary Items
Diluted EPS Including Extraordinary Items
Diluted EPS Excluding Extraordinary Items
Normalised Income Before Taxes
Normalised Income After Taxes
Normalised Income Available to Common Shareholders
Diluted Normalised EPS	304	382	873	-299	462
Dividends per Share